Crucial Role of Jak2V617f-positive Myeloproliferative Neoplasm in the Development of Aortic Aneurysm

被引：0
|
作者：
Yokokawa, Tetsuro
Misaka, Tomofumi
Kimishima, Yusuke
Wada, Kento
Minakawa, Keiji
Sugimoto, Koichi
Ishida, Takafumi
Ikeda, Kazuhiko
Takeishi, Yasuchika
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
10.1161/circ.142.suppl_3.12726
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12726
引用
收藏
页数：2
相关论文
共 50 条
  • [41] JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
    Nauroy, P.
    Delhommeau, F.
    Baklouti, F.
    BLOOD CANCER JOURNAL, 2014, 4 : e222 - e222
  • [42] JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
    P Nauroy
    F Delhommeau
    F Baklouti
    Blood Cancer Journal, 2014, 4 : e222 - e222
  • [43] Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia
    E Puigdecanet
    B Espinet
    J J Lozano
    L Sumoy
    B Bellosillo
    L Arenillas
    A Álvarez-Larrán
    F Solé
    S Serrano
    C Besses
    L Florensa
    Leukemia, 2008, 22 : 1368 - 1376
  • [44] Morphologic Evaluation of CALR and JAK2V617F-Positive Primary Myelofibrosis (PMF)
    Wood, Adam
    Viswanatha, David
    Reichard, Kaaren
    Hanson, Curtis
    Chen, Dong
    Tefferi, Ayalew
    He, Rong
    LABORATORY INVESTIGATION, 2015, 95 : 387A - 387A
  • [45] Morphologic Evaluation of CALR and JAK2V617F-Positive Primary Myelofibrosis (PMF)
    Wood, Adam
    Viswanatha, David
    Reichard, Kaaren
    Hanson, Curtis
    Chen, Dong
    Tefferi, Ayalew
    He, Rong
    MODERN PATHOLOGY, 2015, 28 : 387A - 387A
  • [46] The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
    Orbell, Lai Yee
    Abutheraa, Nouf
    Duncombe, Andrew S.
    Mcmullin, Mary Frances
    Mesa, Ruben
    Mcshane, Charlene M.
    James, Glen
    Anderson, Lesley A.
    EJHAEM, 2023, 4 (04): : 1071 - 1080
  • [47] EPIGENETIC CHANGES IN JAK2V617F POSITIVE MYELOPROLIFERATIVE DISORDERS
    Uras, A.
    Fancello, M. A.
    Monne, M.
    Piras, G.
    Palmas, A. D.
    Gaviano, E.
    Noli, A.
    Bianchi, A.
    Gabbas, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 356 - 356
  • [48] JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate
    Nielsen, Camilla
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Kofoed, Klaus F.
    Birgens, Henrik S.
    HAEMATOLOGICA, 2014, 99 (09) : 1448 - 1455
  • [49] Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm
    Helman, Ricardo
    Pereira, Welbert de O.
    Marti, Luciana C.
    Campregher, Paulo V.
    Puga, Renato Davi
    Hamerschlak, Nelson
    Chiattone, Carlos S.
    Santos, Fabio Pires de S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (03) : 443 - 445
  • [50] Plummer-Vinson syndrome and reactive thrombocytosis mask a JAK2-V617F positive myeloproliferative neoplasm
    Scott, Emma Catherine
    Schuster, Stephen
    BLOOD, 2011, 118 (23) : 5988 - 5988
12345